Hopital Laval

Ste-Foy, Quebec GIV 4G5

0 studies enrolling now · 10 studies all time

What they study most

Breast Cancer, Carcinoma, Non-small-cell Lung, Cardiovascular Disease, Cardiovascular Diseases, Heart Diseases, Heart Enlargement, Heart Failure, Heart Failure, Congestive, Myocardial Infarction, Non-small Cell Lung Cancer, Ovarian Cancer, Pancreatic Cancer

Studies at this site

• Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD Patients — Completed
• ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer — Completed
• OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer — Completed
• OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. — Completed
• Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function — Completed
• 12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD — Completed
• Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer — Completed
• A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) — Completed
• Study of Oral PG-116800 Following a Heart Attack — Completed
• Phase II Study To Evaluate The Safety and Efficacy of Hemoglobin Raffimer in Patients Undergoing First Time CABG Surgery — Paused